| __timestamp | Catalyst Pharmaceuticals, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 1595000 |
| Thursday, January 1, 2015 | 11801342 | 11434000 |
| Friday, January 1, 2016 | 11369941 | 26546000 |
| Sunday, January 1, 2017 | 11375237 | 39778000 |
| Monday, January 1, 2018 | 19919204 | 53418000 |
| Tuesday, January 1, 2019 | 18842752 | 111997000 |
| Wednesday, January 1, 2020 | 16496715 | 139507000 |
| Friday, January 1, 2021 | 16936000 | 195958000 |
| Saturday, January 1, 2022 | 19789000 | 248149000 |
| Sunday, January 1, 2023 | 93150000 | 232366000 |
Unleashing insights
In the competitive landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Catalyst Pharmaceuticals, Inc. and ImmunityBio, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, ImmunityBio, Inc. consistently outpaced Catalyst Pharmaceuticals, Inc. in R&D spending, with a peak in 2022 where their investment was nearly 13 times higher than in 2014. Catalyst Pharmaceuticals, Inc., however, showed a significant surge in 2023, increasing their R&D expenses by over 370% compared to the previous year. This dramatic rise suggests a strategic pivot towards innovation. As these companies continue to evolve, their R&D spending patterns offer valuable insights into their future trajectories and potential breakthroughs in the pharmaceutical industry.
Analyzing R&D Budgets: Amgen Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Catalyst Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited